GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vericel Corp (FRA:ATQP) » Definitions » Sale Of Investment

Vericel (FRA:ATQP) Sale Of Investment : €49.2 Mil (TTM As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Vericel Sale Of Investment?

Vericel's sale of investment for the three months ended in Dec. 2024 was €14.1 Mil. It means Vericel gained €14.1 Mil from selling investments. Vericel's sale of investment for the trailing twelve months (TTM) ended in Dec. 2024 was €49.2 Mil.

Compared with last quarter (€13.6 Mil in Sep. 2024 ), Vericel gained more money from selling investments in Dec. 2024 (€14.1 Mil).

Vericel Sale Of Investment Historical Data

The historical data trend for Vericel's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vericel Sale Of Investment Chart

Vericel Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.89 57.03 38.65 73.00 50.76

Vericel Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.16 10.23 11.32 13.61 14.07

Vericel Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €49.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vericel Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Vericel's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Vericel Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vericel Corp (FRA:ATQP) » Definitions » Sale Of Investment
Comparable Companies
MIRM BEAM BHVN MTSR NAMS TARS LGND APGE JANX KYMR VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
VCEL:USA ATQP:Germany
Address
64 Sidney Street, Cambridge, MA, USA, 02139
Website
https://www.vcel.com
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Vericel Headlines

No Headlines